Catalyst Wire Dossier Catalyst Wire Dossier

Tregalizumab

regalizumab · Biotest
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tregalizumab, covering 2017-08-24 to 2022-02-08. Get the full timeline:

Most recent: Clinical Trial Update: Effects of Tregalizumab on Allergen-induced Airway Responses and Airway Inflammation in Asthmatic Patients [Phase 2]

See pricing